BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jafari A, Babajani A, Abdollahpour-Alitappeh M, Ahmadi N, Rezaei-Tavirani M. Exosomes and cancer: from molecular mechanisms to clinical applications. Med Oncol 2021;38:45. [PMID: 33743101 DOI: 10.1007/s12032-021-01491-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Babajani A, Hosseini-Monfared P, Abbaspour S, Jamshidi E, Niknejad H. Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19. Front Cell Dev Biol 2021;9:695362. [PMID: 34179022 DOI: 10.3389/fcell.2021.695362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jafari A, Rezaei-Tavirani M, Niknejad H, Zali H. Tumor Targeting by Conditioned Medium Derived From Human Amniotic Membrane: New Insight in Breast Cancer Therapy. Technol Cancer Res Treat 2021;20:15330338211036318. [PMID: 34402329 DOI: 10.1177/15330338211036318] [Reference Citation Analysis]
3 Ginini L, Billan S, Fridman E, Gil Z. Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate. Cells 2022;11:1375. [DOI: 10.3390/cells11091375] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Moeinabadi-Bidgoli K, Babajani A, Yazdanpanah G, Farhadihosseinabadi B, Jamshidi E, Bahrami S, Niknejad H. Translational insights into stem cell preconditioning: From molecular mechanisms to preclinical applications. Biomed Pharmacother 2021;142:112026. [PMID: 34411911 DOI: 10.1016/j.biopha.2021.112026] [Reference Citation Analysis]
5 Olmeda D, Cerezo-Wallis D, Castellano-Sanz E, García-Silva S, Peinado H, Soengas MS. Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles. Adv Drug Deliv Rev 2021;175:113833. [PMID: 34147531 DOI: 10.1016/j.addr.2021.113833] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
6 Tallima H, Azzazy HME, El Ridi R. Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion. Lipids Health Dis 2021;20:150. [PMID: 34717628 DOI: 10.1186/s12944-021-01581-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jafari A, Babajani A, Rezaei-Tavirani M. Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches. Biomark Insights 2021;16:11772719211013352. [PMID: 34017167 DOI: 10.1177/11772719211013352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Di Santo R, Romanò S, Mazzini A, Jovanović S, Nocca G, Campi G, Papi M, De Spirito M, Di Giacinto F, Ciasca G. Recent Advances in the Label-Free Characterization of Exosomes for Cancer Liquid Biopsy: From Scattering and Spectroscopy to Nanoindentation and Nanodevices. Nanomaterials (Basel) 2021;11:1476. [PMID: 34199576 DOI: 10.3390/nano11061476] [Reference Citation Analysis]
9 Yang B, Teng F, Chang L, Wang J, Liu DL, Cui YS, Li GH. Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small cell lung cancer. Aging (Albany NY) 2021;13:13264-86. [PMID: 33952725 DOI: 10.18632/aging.203011] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Palinski W, Monti M, Camerlingo R, Iacobucci I, Bocella S, Pinto F, Iannuzzi C, Mansueto G, Pignatiello S, Fazioli F, Gallo M, Marra L, Cozzolino F, De Chiara A, Pucci P, Bilancio A, de Nigris F. Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients. Cell Death Dis 2021;12:797. [PMID: 34404763 DOI: 10.1038/s41419-021-04069-w] [Reference Citation Analysis]
11 Jafari A, Babajani A, Sarrami Forooshani R, Yazdani M, Rezaei-Tavirani M. Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside. Front Oncol 2022;12:819563. [PMID: 35280755 DOI: 10.3389/fonc.2022.819563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Babajani A, Moeinabadi-Bidgoli K, Niknejad F, Rismanchi H, Shafiee S, Shariatzadeh S, Jamshidi E, Farjoo MH, Niknejad H. Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation. Stem Cell Res Ther 2022;13:126. [PMID: 35337387 DOI: 10.1186/s13287-022-02794-3] [Reference Citation Analysis]
13 Romanò S, Di Giacinto F, Primiano A, Gervasoni J, Mazzini A, Papi M, Urbani A, Serafino A, De Spirito M, Krasnowska EK, Ciasca G. Label-free spectroscopic characterization of exosomes reveals cancer cell differentiation. Analytica Chimica Acta 2022;1192:339359. [DOI: 10.1016/j.aca.2021.339359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gulati R, Nandi D, Sarkar K, Venkataraman P, Ramkumar KM, Ranjan P, Janardhanan R. Exosomes as Theranostic Targets: Implications for the Clinical Prognosis of Aggressive Cancers. Front Mol Biosci 2022;9:890768. [DOI: 10.3389/fmolb.2022.890768] [Reference Citation Analysis]